Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants
Advances in Nutrition · 2026
DOI: 10.1016/j.advnut.2025.100585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Nutrition, 2026. Verfasst von Steven A Abrams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States. Electronic address: sabrams@austin.utexas.edu. Hauptthemen laut MEDLINE: Infant, Premature, Infant Formula, Breast Feeding, Infant Nutritional Physiological Phenomena. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cattlemen's Beef Association.
Themen: Neonatologie, Hebammenwesen und Geburtshilfe, Stillen
Abstract (Originalsprache)
The United States formula industry uses aggressive marketing strategies that exploit parental anxieties, undermine breastfeeding, and violate ethical international standards, all of which contribute to early formula introduction and disparities in breastfeeding. In addition, misleading or complex labeling contributes to caregiver and provider confusion regarding the content of formulas. A centralized, Food and Drug Administration-maintained database of infant formulas could support caregivers and healthcare professionals in countering misinformation and making evidence-based decisions. Human milk remains the reference standard for infant nutrition, with strong evidence supporting its role in reducing morbidity and mortality, especially in the neonatal intensive care unit (NICU). Despite this, disparities persist in breastfeeding rates, particularly among Black and Hispanic mothers. These are driven by structural barriers, including lack of paid parental leave and inadequate lactation support. Donor human milk (DHM) is the recommended alternative for high-risk infants in the NICU when the mother's own milk is unavailable. However, due to lack of federal funding and oversight, high cost and inconsistent insurance coverage, the use of DHM is limited, especially in safety-net hospitals. Specialized hypoallergenic and metabolic formulas are essential for managing medical conditions including cow's milk-protein allergy and inborn errors of metabolism. These are regulated as exempt formulas but must meet rigorous clinical standards. In the NICU, adequate early nutrition for preterm infants is crucial to reduce morbidity and mortality and improve long-term neurodevelopmental outcomes. Human milk fortifiers are composed of similar ingredients to infant formula and are used to improve the nutritional content of feedings given in the NICU and postdischarge. The use of live biotherapeutic products or probiotics as additives to preterm infants has been demonstrated in multiple studies to reduce the incidence of necrotizing enterocolitis, late-onset sepsis, and all-cause mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States. Electronic address: sabrams@austin.utexas.edu.
- Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States.
- Department of Regulatory and Quality Sciences, USC Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.
- Department of Pediatrics, The Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Chicago, IL, United States.
- Center for Nutrition, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA, United States.
- Clinical Nutrition, Stanford Medicine Children's Health, Palo Alto, CA, United States.
Förderung
- National Cattlemen's Beef Association
Zitieren
APA
Abrams, S. A., Brenna, J. T., Clemens, R., Cohran, V. C., Du, N., Gilbaugh, A., Goran, M. I., Guild, A., Kerner, J. A., Knudsen, T. B., Krishna, S., & Sentongo, T. (2026). Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants. Advances in Nutrition. https://doi.org/10.1016/j.advnut.2025.100585
Vancouver
Abrams SA, Brenna JT, Clemens R, Cohran VC, Du N, Gilbaugh A, et al. Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants. Advances in Nutrition. 2026. doi:10.1016/j.advnut.2025.100585
BibTeX
@article{Abrams2026,
author = {Abrams, Steven A and Brenna, James Thomas and Clemens, Roger and Cohran, Valeria C and Du, Nan and Gilbaugh, Andrea and Goran, Michael I and Guild, Analeise and Kerner, John A and Knudsen, Thomas B and Krishna, Sushma and Sentongo, Timothy},
title = {Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants},
journal = {Advances in Nutrition},
year = {2026},
doi = {10.1016/j.advnut.2025.100585}
}
EUVIMED